GlaxoSmithKline announced FDA approval for Arnuity Ellipta (fluticasone furoate inhalation powder), a once-daily inhaled corticosteroid medicine for the treatment of asthma in patients 12 years of age and older.
Pop star Katy Perry has unveiled her newest fragrance, dubbed Killer Queen’s Royal Revolution by Katy Perry.
Brandperx in November will be launching its Patientperx platform, a diseases-state specific health resource that's being published in partnership with Reader's Digest.
Pharmavite’s VitaMelts brand has been a popular introduction to the category, with $9.4 million in sales, up 184.3%, for the 52 weeks ended June 15 across total U.S. multi-outlets, according to IRI.
The successful introduction of Estroven Weight Management is bringing new users to the menopause supplement category, said April Mills, marketing director of i-Health, a division of DSM.
Procter & Gamble’s ZzzQuil was named to IRI’s list of new product pacesetters this year.
Meda Consumer Healthcare’s MidNite for Menopause last year was honored as one of Parade magazine’s top new products of the year.
Bayer Diagnostics’ Contour Next portfolio has been performing exceptionally well lately, generating $12.4 million in front-end sales, up 226.6% for the 52 weeks ended June 15 across total U.S. multi-outlets, according to IRI.
iHealth Lab recently launched its iHealth Align, one of the world’s smallest, FDA-approved mobile blood-glucose monitors.
Pfizer successfully switched Nexium to over-the-counter in late May, and with that brought a $6 billion book of prescription business to antacid aisles, according to IMS Health data compiled over 2012.